Literature DB >> 18305131

Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex.

K G P Hoek1, N C Gey van Pittius, H Moolman-Smook, K Carelse-Tofa, A Jordaan, G D van der Spuy, E Streicher, T C Victor, P D van Helden, R M Warren.   

Abstract

The emergence and transmission of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) have raised concern about diagnostic delay associated with culture-based drug susceptibility testing methods. The association between rifampin resistance and MDR-TB or XDR-TB makes it an important genetic marker for genotypic drug susceptibility testing. In this article, we describe the analysis of the physical properties of the rifampin resistance-determining region (RRDR) in the rpoB gene by high-resolution thermal melt analysis as a method for detecting rifampin resistance in Mycobacterium tuberculosis complex. The RRDR from the M. tuberculosis complex was amplified by PCR from DNA templates extracted from sputum cultures of M. tuberculosis or the laboratory strain (H37Rv) in the presence of a fluorescent DNA binding dye. Subsequent mixing of the amplification products from the respective sputum cultures and the laboratory strain and thermocycling allowed the formation of DNA duplexes. The thermal denaturation properties of these DNA duplexes were determined by measuring the derivative of the intensity of fluorescence at different temperatures. Analysis of DNA extracted from 153 sputum cultures showed a sensitivity of 98% and a specificity of 100% for the detection of rifampin resistance compared to the "gold standard" culture-based phenotyping method. No statistical difference was detected in the performance of the method when applied to crude DNA from 134 boiled cultures. This method, named "FAST-Rif" ("fluorometric assay for susceptibility testing of rifampin"), allowed the rapid, reliable, and easy detection of genotypic rifampin resistance as a marker for MDR-TB and XDR-TB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305131      PMCID: PMC2292920          DOI: 10.1128/JCM.02343-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy.

Authors:  T C Victor; A M Jordaan; A van Rie; G D van der Spuy; M Richardson; P D van Helden; R Warren
Journal:  Tuber Lung Dis       Date:  1999

Review 2.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

3.  MODS assay for the diagnosis of TB.

Authors:  Rumina Hasan; Seema Irfan
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

Review 4.  High-resolution DNA melting analysis for simple and efficient molecular diagnostics.

Authors:  Gudrun H Reed; Jana O Kent; Carl T Wittwer
Journal:  Pharmacogenomics       Date:  2007-06       Impact factor: 2.533

5.  Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis.

Authors:  A G M Van Der Zanden; E M Te Koppele-Vije; N Vijaya Bhanu; D Van Soolingen; L M Schouls
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

6.  Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.

Authors:  V Kapur; L L Li; S Iordanescu; M R Hamrick; A Wanger; B N Kreiswirth; J M Musser
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin.

Authors:  R Rossau; H Traore; H De Beenhouwer; W Mijs; G Jannes; P De Rijk; F Portaels
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

8.  Simple, phage-based (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum.

Authors:  H Albert; A Trollip; T Seaman; R J Mole
Journal:  Int J Tuberc Lung Dis       Date:  2004-09       Impact factor: 2.373

9.  Patients with active tuberculosis often have different strains in the same sputum specimen.

Authors:  Robin M Warren; Thomas C Victor; Elizabeth M Streicher; Madalene Richardson; Nulda Beyers; Nicolaas C Gey van Pittius; Paul D van Helden
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405

10.  RIDOM: comprehensive and public sequence database for identification of Mycobacterium species.

Authors:  Dag Harmsen; Stefan Dostal; Andreas Roth; Stefan Niemann; Jörg Rothgänger; Michael Sammeth; Jürgen Albert; Matthias Frosch; Elvira Richter
Journal:  BMC Infect Dis       Date:  2003-11-11       Impact factor: 3.090

View more
  17 in total

1.  Use of a high-resolution melt assay to characterize codon 54 of the cyp51A gene of Aspergillus fumigatus on a Rotor-Gene 6000 instrument.

Authors:  M J Tuohy; V Reja; S Park; D S Perlin; M Wnek; G W Procop; B Yen-Lieberman
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

2.  Gene Scanning of an Internalin B Gene Fragment Using High-Resolution Melting Curve Analysis as a Tool for Rapid Typing of Listeria monocytogenes.

Authors:  Ariane T Pietzka; Anna Stöger; Steliana Huhulescu; Franz Allerberger; Werner Ruppitsch
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

3.  Genotyping of Mycobacterium tuberculosis Rifampin Resistance-Associated Mutations by Use of Data from Xpert MTB/RIF Ultra Enables Large-Scale Tuberculosis Molecular Epidemiology Studies.

Authors:  Brian Weinrick
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

4.  Rapid detection of multidrug-resistant Mycobacterium tuberculosis by use of real-time PCR and high-resolution melt analysis.

Authors:  Melissa V Ramirez; Kelley C Cowart; Patricia J Campbell; Glenn P Morlock; David Sikes; Jonas M Winchell; James E Posey
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

5.  Rapid diagnosis of Old World Leishmaniasis by high-resolution melting analysis of the 7SL RNA gene.

Authors:  Abedelmajeed Nasereddin; Charles L Jaffe
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

6.  High-resolution melting curve analysis for rapid detection of rifampin resistance in Mycobacterium tuberculosis: a meta-analysis.

Authors:  Xiaomao Yin; Lei Zheng; Qinlan Liu; Li Lin; Xiumei Hu; Yanwei Hu; Qian Wang
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

7.  Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China.

Authors:  Xiaoliang Yuan; Tiantuo Zhang; Kazuyoshi Kawakami; Jiaxin Zhu; Hongtao Li; Jianping Lei; Shaohua Tu
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

8.  High-resolution melting curve analysis for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates.

Authors:  Go Eun Choi; Sun Min Lee; Jongyoun Yi; Sang Hyun Hwang; Hyung Hoi Kim; Eun Yup Lee; Eun Hae Cho; Jee Hee Kim; Hwa-Jung Kim; Chulhun L Chang
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

9.  Development and Validation of a High-Resolution Melting Assay To Detect Azole Resistance in Aspergillus fumigatus.

Authors:  L Bernal-Martínez; H Gil; O Rivero-Menéndez; S Gago; M Cuenca-Estrella; E Mellado; A Alastruey-Izquierdo
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

10.  Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis.

Authors:  Danny C T Ong; Wing-Cheong Yam; Gilman K H Siu; Ann S G Lee
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.